Pretransplant comorbidity as an outcome predictor in adult patients younger than 60 years of age receiving standard induction chemotherapy for de novo acute myeloid leukemia Nilotinib in chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results